Safety of treatment with biologics for psoriasis in daily practice: 5-year data

@inproceedings{Lmig2010SafetyOT,
  title={Safety of treatment with biologics for psoriasis in daily practice: 5-year data},
  author={P P M van L{\"u}mig and R J B Driessen and M A M Berends and Jan B. M. Boezeman and Pcm van de Kerkhof and Emgj de Jong},
  booktitle={Journal of the European Academy of Dermatology and Venereology : JEADV},
  year={2010}
}
BACKGROUND The cumulative exposition to biologics is increasing with prolonged treatment with a certain biologic or consecutive biological treatment. However, long-term safety data are limited available. OBJECTIVES The aim of this study was to prospectively evaluate the 5-year safety of biological treatment for psoriasis in daily practice. METHODS A cohort of 173 psoriasis patients on biologics was prospectively followed for 5 years. All adverse events reported were documented and analysed… CONTINUE READING